Evidence map›Paper›PMID 40269270›Full record

ArticleLeukemia2025

National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients.

James Fan Wu, Erin Jay G Feliciano, Angelica Singh, Douglas Tremblay, Muhammad Bilal Abid, Edward Christopher Dee

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James Fan Wu *Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. jwu@mcw.edu.ORCID http://orcid.org/0000-0001-7447-6173
Erin Jay G FelicianoDepartment of Medicine, NYC+HHC/Elmhurst, Icahn School of Medicine at Mount Sinai, Queens, NY, USA.
Angelica SinghDivision of Hematology & Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Douglas TremblayDivision of Hematology & Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-4719-7192
Muhammad Bilal AbidDepartment of Hematology/Oncology, UT Houston McGovern School of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1128-0445
Edward Christopher Dee *Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-6119-0889

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Medical College of Wisconsin Physician Scientist Immersion ProgramR38HL167238 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MARY EAPEN, Michael E Widlansky · 2023 to 2026
$948k
NCI NIH HHS P30 CA008748Prostate Cancer Foundation (PCF) Young Investigator AwardU.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R38HL167238
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40269270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.